
- Pharmaceutical Technology, September 2024
- Volume 48
- Issue 9
- Pages: 10
Virus Removal Filters
Asahi Kasei Medical now offers its Planova virus removal filters for use in biopharma manufacturing and plasma derivatives manufacturing.
Asahi Kasei Medical’s Planova virus removal filters are used in the manufacturing processes of biopharmaceuticals and plasma derivatives. The filters are also used in biosafety testing services and biopharmaceutical contract development and manufacturing operations. Planova comprises cellulose hollow-fiber membrane filters that were developed to specifically remove viruses from biotherapeutic products. The line was launched in 1989 and was followed by Planova BioEX hydrophilic polyvinylidene fluoride hollow-fiber membrane filters in 2009. Both product lines have been adopted worldwide. The latest offering is Planova S20N, a next-generation line of cellulose hollow-fiber membrane filters, which was launched in 2022. This latest addition features robust virus removal capability and simplified operation.
Articles in this issue
about 1 year ago
Understanding the Value of Excipient Gradeabout 1 year ago
Determining Low PPB Levels of Nitrite in Polymeric Excipientsabout 1 year ago
Molecular Modeling in Formulation Developmentabout 1 year ago
Advancing Robotic Automationabout 1 year ago
Meeting Adventitious Agent Testing Needs for Complex Modalitiesabout 1 year ago
It’s All About the Small Thingsabout 1 year ago
Responding to Mpoxabout 1 year ago
Strategic Decarbonizationabout 1 year ago
Keeping Audit and Inspection Programs Currentabout 1 year ago
European Artificial Intelligence Act Comes into ForceNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




